Hengrui Pharma (1276 HK): Trying to Achieve Total Global Index Inclusion
Hengrui Pharma's (1276 HK) inclusion in Global Standard in August 2025 is less likely than its forecasted addition to Global All-World in December...
573 Views
ECM Weekly (26 May 2025) - CATL, Hengrui, Eastroc, Haitian, Schloss, Aegis, Hyundai Marine, Pony
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
593 Views
China Healthcare Weekly (May.18) - Trump to Lower US Drug Prices, Thoughts on Hengrui's IPO Pricing
Hengrui's HK IPO debut is strong, driven by positive sentiment for AH listing and the small IPO size (225 million circulating shares). Investors...
848 Views
Jiangsu Hengrui Pharma A/H Trading - Strong Demand for Quality Asset, but Is Pricey
Jiangsu Hengrui Pharmaceuticals (1276 HK) (JHP, 600276 CH ), a China-based pharmaceutical company, raised around US$1.5bn in its H-share listing....
481 Views
Jiangsu Hengrui Pharma H Share Listing (1276 HK): Trading Debut
Hengrui had the highest oversubscription rates among recent large AH listings. The AH discount implied by the offer is attractive.
723 Views